Should automated ad reporting replace creative diagnosis?
Should automated ad reporting replace creative diagnosis?
Automated ad reporting should not replace creative diagnosis. Dashboards summarize outcomes; they do not tell you which hook to shoot next. Read hook rate and hold against your baseline, then decide what to make. eonik is a Mac app for research plus on-brand cuts, not a reporting product; You approve every export; eonik never spends.
Should automated ad reporting replace creative diagnosis?
Automated ad reporting should not replace creative diagnosis. Dashboards summarize outcomes; they do not tell you which hook to shoot next. Read hook rate and hold against your baseline, then decide what to make. eonik is a Mac app for research plus on-brand cuts, not a reporting product; You approve every export; eonik never spends.
Reporting summarizes; diagnosis decides
Reporting tools aggregate CPA, spend, and asset labels. Creative diagnosis asks whether the opening failed, the body broke promise, or the offer mismatched. Then names the next isolated test.
A green dashboard does not write your hook menu. Neither does a red one.
Metrics that steer production
Hook rate uses Meta’s 3-second video plays divided by impressions. Hold uses ThruPlays divided by 3-second plays. Meta documents both; it does not publish a universal good bar.
When hook is strong and hold dies, the body failed the promise. That is a new experiment, not a reason to automate pauses.
- 1. Read hook and hold vs your baseline, not a published benchmark.
- 2. Name the failed slot: hook, body, CTA, or offer.
- 3. Make the next kit-locked cut in eonik; approve it.
- 4. You still launch and pause in Ads Manager.
Reporting is not the product
eonik is not Motion, not a BI layer, and not an autonomous budget tool. It helps you consider what is worth making and assemble the on-brand cut on Mac.
Use reporting where you already trust it. Use eonik when the bottleneck is supply you can actually watch.
Reporting vs creative diagnosis
| Job | Automated reporting | Creative diagnosis + eonik |
|---|---|---|
| Output | Aggregated KPIs. | Next isolated variant to make. |
| Hook failure | Asset label only. | Hook swap on locked body. |
| Spend | Still yours in Ads Manager. | eonik never spends. |
What usually breaks
- Pausing winners because a dashboard color flipped without watching the ad.
- Buying reporting when production is the actual queue.
- Expecting eonik to replace Ads Manager readouts.
Consider what is worth making next, assemble the on-brand cut in eonik on Mac, and approve every frame before upload. The loop is how to generate AI ads. You decide spend in Ads Manager. eonik never spends.
“Almost any question can be answered, cheaply, quickly, and finally, by a test campaign. And that’s the way to answer them, not by arguments around a table.”
That principle still holds. The next on-brand cut is yours to approve.
Sources
FAQ
Should automated ad reporting replace creative diagnosis?
No. Reporting summarizes outcomes; creative diagnosis names which slot failed and what to test next. Read hook rate and hold against your baseline, then make kit-locked cuts you approve. eonik is a Mac app for research plus assembly, not a reporting suite; It never spends or predicts; You still decide every launch and pause in Ads Manager.
Is eonik a reporting tool?
No. It helps you consider what is worth making with receipts, then assemble on-brand ads from your footage and AI clips. Use Motion or your BI stack for analytics depth if you need it. eonik when the bottleneck is making variants you will actually watch; Download for Mac at /download; Approve every frame before upload.
Can reporting tell us which hook to shoot?
It can show which asset label lagged, not why the opening failed on a phone speaker. Diagnosis still needs isolation and playback. Meta documents 3-second plays and ThruPlay; there is no official automated hook prescription. Make the next swap in eonik, approve it, upload yourself; Operator experience fills the gap reporting leaves.
Free, no card · macOS 15+ · Apple silicon